Publications by authors named "Bruce R Rowley"

Claim this Profile
B
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models.
Ningshu Liu, Bruce R Rowley, Cathy O Bull, Claudia Schneider, Andrea Haegebarth

Mol Cancer Ther· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics.
Kristen A Kellar, Matthew V Lorenzi, Ching Ping Ho, Dan You, Mei-Li Wen, Bruce R Rowley

Mol Cancer Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.
Joan M Carboni, Adrian V Lee, Darryl L Hadsell, Bruce R Rowley, Francis Y Lee

Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis